Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
822.00    0.00 (0.00%)
Bid:
822.00
Ask:
830.00
Spread: 8.00 (0.973%)
Market Cap: £378.91m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Trading Update

15 Sep 2015 07:00

RNS Number : 0229Z
Porvair PLC
15 September 2015
 

For immediate release

15 September 2015

 

 

 

Porvair plc ("Porvair")

 

Trading update

 

 

Porvair plc ("Porvair"), the specialist filtration and environmental technology group today issues the following trading update for the nine months to 31 August 2015.

 

Porvair continued to trade well. Underlying revenues (1) for the nine months to 31 August 2015 were 9% higher than in the first nine months of 2014.

 

As previously reported, there will not be a recurrence in 2015 of the unusually high revenues recognised from several large projects in 2014. Total revenues are therefore 9% lower than the prior year. Profit before tax is in line with management's expectation.

 

Underlying revenues in the Microfiltration division were 13% ahead of the prior period. Progress towards commissioning of the large projects (gasification projects for POSCO, Reliance and CNOOC and a UK nuclear remediation contract) continued as anticipated. The Metals Filtration division traded in line with management's expectations, 1% ahead of the prior period (in constant currency: 7% below the prior period). Order books for the final quarter are satisfactory.

 

New plants in the UK and USA opened in the first half. The expansion of the China facility is on schedule and to budget. A new facility in Ashland, VA, has been leased and is expected to be occupied by around the end of the first quarter 2016.

 

At 31 August 2015, the Group had a net cash of £9m (31 August 2014: net debt of £0.3m).

 

Note (1) Underlying revenue: Revenue excluding the impact of large projects.

 

For further information, please contact:

 

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

Buchanan

0207 466 5000

Charles Ryland / Stephanie Watson

 

 

 

 

 

Notes to Editors

 

Porvair is a group of specialist filtration and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. Its principal markets are aviation, energy and industrial process, environmental laboratories and non-ferrous metals.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQZLFFEKFZBBF
Date   Source Headline
27th Mar 20257:00 amRNSGrant of SAYE Options
18th Mar 20257:40 amRNSHolding(s) in Company
17th Mar 20253:30 pmRNSHolding(s) in Company
14th Mar 20257:00 amRNSNotice of Annual General Meeting; Accounts posting
4th Mar 20253:00 pmRNSHolding(s) in Company
12th Feb 20252:30 pmRNSDirector/PDMR Shareholding
10th Feb 20257:00 amRNSFull Year Results
12th Dec 20241:00 pmRNSHolding(s) in Company
10th Dec 20247:00 amRNSTrading update and notice of results
2nd Dec 20243:01 pmRNSTotal Voting Rights
2nd Dec 20243:00 pmRNSDirector/PDMR Shareholding
25th Nov 20244:37 pmRNSShareholder Communications
28th Oct 20247:00 amRNSBoard appointment
1st Oct 20247:00 amRNSTotal Voting Rights
23rd Sep 20247:00 amRNSAppointment of Chief Executive Officer
2nd Sep 20245:15 pmRNSDirector/PDMR Shareholding
2nd Sep 20245:00 pmRNSTotal Voting Rights
31st Jul 202410:45 amRNSTotal Voting Rights
31st Jul 202410:30 amRNSBlock listing Interim Review
29th Jul 20246:15 pmRNSDirector/PDMR Shareholding
1st Jul 20247:00 amRNSInterim Results
27th Jun 20242:26 pmRNSDirector/PDMR Shareholding
23rd Apr 20241:38 pmRNSDirector/PDMR Shareholding
16th Apr 20242:56 pmRNSAGM Results Announcement
16th Apr 20247:00 amRNSAGM Trading Update & Board Update
3rd Apr 20247:00 amRNSDirector resignation
12th Mar 20247:00 amRNSDirector declaration
29th Feb 20247:00 amRNSTotal Voting Rights
8th Feb 20244:41 pmRNSHolding(s) in Company
8th Feb 20244:27 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSResults for the year ended 30 November 2023
1st Feb 20247:00 amRNSBlock listing Interim Review
19th Dec 202310:25 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSTrading Update & Acquisition
4th Dec 202312:00 pmRNSHolding(s) in Company
25th Sep 202310:00 amRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSNine Month Trading Update
21st Aug 20237:00 amRNSDirector/PDMR Shareholding
17th Jul 20237:00 amRNSAcquisition completion
7th Jul 20234:00 pmRNSBlock Listing Application
3rd Jul 20237:00 amRNSInterim Results
26th Jun 20237:00 amRNSBoard Change
21st Jun 20234:22 pmRNSHolding(s) in Company
21st Jun 20237:00 amRNSDirector/PDMR Shareholding
15th Jun 20237:00 amRNSBlock listing Interim Review
4th May 20237:00 amRNSAcquisitions
18th Apr 202312:51 pmRNSAGM resolutions
18th Apr 20237:00 amRNSAGM Trading Update
31st Mar 20234:00 pmRNSTotal Voting Rights
22nd Mar 20233:03 pmRNSGrant of options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.